NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

DCVAX-L is a platform technology, Linda Power's own words. DCVAX-L's effectiveness in treating operable brain tumors means it can be used for any operable cancer. This potential alone along with Direct makes its price tag unaffordable. You also forget Flaskworks. NWBO owns the technology to manufacture Dendritic cell's en masse, priceless in itself once Dendritic cell technology truly takes off. This is a paradigm shift in how treatment is applied for all cancers and for what it is worth potentially any disease in the future. Biologics will rule future treatments and DCVAX technology and Flaskworks is the point of that spear. What price tag do you have for that potential. This will become a storied stock and when it's potential is truly realized by the market and investors the world over will rise quicker than most people realize. All IMHO.